EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Disease-specific safety and efficacy of DOACs vs LMWH for CAT in patients with brain metastases: a real-world analysis

Ali Mushtaq, Omer Ashruf, Mohanad Baroudi, Ahmad Safdar, Alok A Khorana, Dana Angelini

Blood Vessels, Thrombosis & Hemostasis · 2026-11 · 3 (4) · 100197

DOI: 10.1016/j.bvth.2026.100197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2026-11. Verfasst von Ali Mushtaq und 5 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Cleveland Clinic, Cleveland, OH. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Internal Medicine, Cleveland Clinic, Cleveland, OH.
  • Internal Medicine, Indiana University, Indianapolis, IN.
  • Hematology & Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
  • Case Comprehensive Cancer Center, Cleveland, OH.

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Mushtaq, A., Ashruf, O., Baroudi, M., Safdar, A., Khorana, A. A., & Angelini, D. (2026). Disease-specific safety and efficacy of DOACs vs LMWH for CAT in patients with brain metastases: a real-world analysis. Blood Vessels, Thrombosis & Hemostasis, 3(4), 100197. https://doi.org/10.1016/j.bvth.2026.100197

Vancouver

Mushtaq A, Ashruf O, Baroudi M, Safdar A, Khorana AA, Angelini D. Disease-specific safety and efficacy of DOACs vs LMWH for CAT in patients with brain metastases: a real-world analysis. Blood Vessels, Thrombosis & Hemostasis. 2026;3(4):100197. doi:10.1016/j.bvth.2026.100197

BibTeX
@article{Mushtaq2026,
  author = {Mushtaq, Ali and Ashruf, Omer and Baroudi, Mohanad and Safdar, Ahmad and Khorana, Alok A and Angelini, Dana},
  title = {Disease-specific safety and efficacy of DOACs vs LMWH for CAT in patients with brain metastases: a real-world analysis},
  journal = {Blood Vessels, Thrombosis & Hemostasis},
  year = {2026},
  volume = {3},
  number = {4},
  pages = {100197},
  doi = {10.1016/j.bvth.2026.100197}
}
Kostenlos starten →